Kuru in the 21st century - an acquired human prion disease with very long incubation periods

被引:258
作者
Collinge, John [1 ]
Whitfield, Jerome
McKintosh, Edward
Beck, John
Mead, Simon
Thomas, Dafydd J.
Alpers, Michael P.
机构
[1] UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England
[2] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England
[3] Papua New Guinea Inst Med Res, Goroka, EHP, Papua N Guinea
[4] Curtin Univ Technol, Ctr Int Hlth, Perth, WA 6001, Australia
基金
英国医学研究理事会; 英国惠康基金;
关键词
D O I
10.1016/S0140-6736(06)68930-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Kuru provides the principal experience of epidemic human prion disease. Its incidence has steadily fallen after the abrupt cessation of its route of transmission (endocannibalism) in Papua New Guinea in the 1950s. The onset of variant Creutzfeldt-Jakob disease (vCJD), and the unknown prevalence of infection after the extensive dietary exposure to bovine spongiform encephalopathy (BSE) prions in the UK, has led to renewed interest in kuru. We investigated possible incubation periods, pathogenesis, and genetic susceptibility factors in kuru patients in Papua New Guinea. Methods We strengthened active kuru surveillance in 1996 with an expanded field team to investigate all suspected patients. Detailed histories of residence and exposure to mortuary feasts were obtained together with serial neurological examination, if possible. Findings We identified 11 patients with kuru from July, 1996, to June, 2004, all living in the South Fore. All patients were born before the cessation of cannibalism in the late 1950s. The minimum estimated incubation periods ranged from 34 to 41 years. However, likely incubation periods in men ranged from 39 to 56 years and could have been up to 7 years longer. PRNP analysis showed that most patients with kuru were heterozygous at polymorphic codon 129, a genotype associated with extended incubation periods and resistance to prion disease. Interpretation Incubation periods of infection with human prions can exceed 50 years. In human infection with BSE prions, species-barrier effects, which are characteristic of cross-species transmission, would be expected to further increase the mean and range of incubation periods, compared with recycling of prions within species. These data should inform attempts to model variant CJD epidemiology.
引用
收藏
页码:2068 / 2074
页数:7
相关论文
共 36 条
[1]  
ALPERS M, 1987, P451
[2]  
ALPERS MP, 1968, CENTRAL NERVOUS SYST, P234
[3]  
Alpers MP, 1965, NINDB MONOGRAPH, V2, P65
[4]   THE APOLIPOPROTEIN-E ALLELES AS MAJOR SUSCEPTIBILITY FACTORS FOR CREUTZFELDT-JAKOB-DISEASE [J].
AMOUYEL, P ;
VIDAL, O ;
LAUNAY, JM ;
LAPLANCHE, JL .
LANCET, 1994, 344 (8933) :1315-1318
[5]  
[Anonymous], 1979, KURU SORCERY DIS DAN
[6]  
BARLOW RM, 1990, VET REC, V126, P111
[7]   SURVIVAL OF SCRAPIE VIRUS AFTER 3 YEARS INTERNMENT [J].
BROWN, P ;
GAJDUSEK, DC .
LANCET, 1991, 337 (8736) :269-270
[8]   Iatrogenic Creutzfeldt-Jakob disease at the millennium [J].
Brown, P ;
Preece, M ;
Brandel, JP ;
Sato, T ;
McShane, L ;
Zerr, I ;
Fletcher, A ;
Will, RG ;
Pocchiari, M ;
Cashman, NR ;
d'Aignaux, JH ;
Cervenáková, L ;
Fradkin, J ;
Schonberger, LB ;
Collins, SJ .
NEUROLOGY, 2000, 55 (08) :1075-1081
[9]   APOE in non-Alzheimer amyloidoses -: Transmissible spongiform encephalopathies [J].
Chapman, J ;
Cervenáková, L ;
Lee, HS ;
Estupinan, J ;
Richardson, S ;
Vnencak-Jones, CL ;
Gajdusek, DC ;
Korczyn, AD ;
Brown, P ;
Goldfarb, LG .
NEUROLOGY, 1998, 51 (02) :548-553
[10]   Variant Creutzfeldt-Jakob disease [J].
Collinge, J .
LANCET, 1999, 354 (9175) :317-323